[1]
|
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版) [J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205. https://doi.org/10.3760/cma.j.cn112147-20210109-00031
|
[2]
|
Wang, C., Xu, J., Yang, L., et al. (2018) Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in China (The China Pulmonary Health [CPH] Study): A National Cross-Sectional Study. The Lancet, 391, 1706-1717. https://doi.org/10.1016/S0140-6736(18)30841-9
|
[3]
|
Halpin, D.M.G., Celli, B.R., Criner, G.J., et al. (2019) The GOLD Summit on Chronic Obstructive Pulmonary Disease in Low-and Middle-Income Countries. The International Journal of Tuberculosis and Lung Disease, 23, 1131-1141. https://doi.org/10.5588/ijtld.19.0397
|
[4]
|
Zhou, M., Wang, H., Zeng, X., et al. (2019) Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet Journal, 394, 1145-1158. https://doi.org/10.1016/S0140-6736(19)30427-1
|
[5]
|
慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版) [J]. 国际呼吸杂志, 2017, 37(14): 1041-1057. https://doi.org/10.3760/cma.j.issn.1673-436x.2017.14.001
|
[6]
|
Decramer, M., Janssens, W. and Miravitlles, M. (2012) Chronic Obstructive Pulmonary Disease. The Lancet Journal, 379, 1341-1351. https://doi.org/10.1016/S0140-6736(11)60968-9
|
[7]
|
Halpin, D.M.G., Criner, G.J., Papi, A., et al. (2021) Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 203, 24-36. https://doi.org/10.1164/rccm.202009-3533SO
|
[8]
|
Leung, J.M., Niikura, M., Yang, C.W.T., et al. (2020) COVID-19 and COPD. European Respiratory, 56, Article ID: 2002108. https://doi.org/10.1183/13993003.02108-2020
|
[9]
|
国家免疫规划技术工作组流感疫苗工作组. 中国流感疫苗预防接种技术指南(2022-2023) [J]. 中华预防医学杂志, 2022, 56(10): 4-34. https://doi.org/10.3760/cma.j.cn112150-20220825-00840
|
[10]
|
Berry, B.B., Ehlert, D.A., Battiola, R.J., et al. (2001) Influenza Vaccination Is Safe and Immunogenic When Administered to Hospitalized Patients. Vaccine, 19, 3493-3498. https://doi.org/10.1016/S0264-410X(01)00068-8
|
[11]
|
温莹, 何柳, 翟屹, 等. 流行性感冒病毒裂解疫苗和23价肺炎球菌多糖疫苗改善老年人慢性阻塞性肺疾病的社区干预试验[J]. 中华流行病学杂志, 2018, 39(6): 792-798. https://doi.org/10.3760/cma.j.issn.0254-6450.2018.06.019
|
[12]
|
Li, Y., Zhang, P., An, Z., et al. (2022) Effectiveness of Influenza and Pneumococcal Vaccines on Chronic Obstructive Pulmonary Disease Exacerbations. Respirology, 27, 844-853. https://doi.org/10.1111/resp.14309
|
[13]
|
Huang, C.L., Nguyen, P.A., Kuo, P., Lian, et al. (2013) Influenza Vaccination and Reduction in Risk of Ischemic Heart Disease among Chronic Obstructive Pulmonary Elderly. Computer Methods and Programs in Biomedicine, 111, 507-511. https://doi.org/10.1016/j.cmpb.2013.05.006
|
[14]
|
许敏锐, 强德仁, 潘英姿, 等. 慢性病患者接种流感疫苗的效果与效益评价[J]. 公共卫生与预防医学, 2020, 31(5): 21-24. https://doi.org/10.3969/j.issn.1006-2483.2020.05.006
|
[15]
|
中华预防医学会, 中华预防医学会疫苗与免疫分会. 肺炎球菌性疾病免疫预防专家共识(2020版) [J]. 中华流行病学杂志, 2020, 41(12): 1945-1979. https://doi.org/10.3760/cma.j.cn112338-20201111-01322
|
[16]
|
Kobayashi, M. (2022) Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices—United States, 2022. Morbidity and Mortality Weekly Report, 71, 109-117. https://doi.org/10.15585/mmwr.mm7104a1
|
[17]
|
Ohshima, N., Nagai, H., Matsui, H., et al. (2014) Sustained Functional Serotype-Specific Antibody after Primary and Secondary Vaccinations with a Pneumococcal Polysaccharide Vaccine in Elderly Patients with Chronic Lung Disease. Vaccine, 32, 1181-1186. https://doi.org/10.1016/j.vaccine.2013.09.060
|
[18]
|
荣恒漠, 杨炯. 肺炎疫苗应用于支气管扩张症及慢性阻塞性肺疾病患者的效果[J]. 武汉大学学报(医学版), 2017, 38(1): 90-95. https://doi.org/10.14188/j.1671-8852.2017.01.022
|
[19]
|
Walters, J.A., Tang, J.N.Q., Poole, P., et al. (2017) Pneumococcal Vaccines for Preventing Pneumonia in Chronic Obstructive Pulmonary Disease. Cochrane Database of Systematic Reviews, 1, CD001390. https://doi.org/10.1002/14651858.CD001390.pub4
|
[20]
|
周志强, 曲建卫, 咸本松, 等. 慢性阻塞性肺疾病患者接种肺炎球菌疫苗疗效的Meta分析[J]. 中华全科医学, 2018, 16(9): 1562-1565, 1574. https://doi.org/10.16766/j.cnki.issn.1674-4152.000425
|
[21]
|
Ignatova, G.L., Avdeev, S.N. and Antonov, V.N. (2021) Comparative Effectiveness of Pneumococcal Vaccination with PPV23 and PCV13 in COPD Patients over a 5-Year Follow-Up Cohort Study. Scientific Reports, 11, Article No. 15948. https://doi.org/10.1038/s41598-021-95129-w
|
[22]
|
邱英鹏, 赵琨, 李雪, 等. 中国农村老年慢性阻塞性肺病患者接种23价肺炎多糖疫苗的卫生经济学评价[J]. 中华预防医学杂志, 2016, 50(12): 1074-1078. https://doi.org/10.3760/cma.j.issn.0253-9624.2016.12.010
|
[23]
|
WHO (2023) WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int
|
[24]
|
中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(试行第十版) [J]. 中华临床感染病杂志, 2023, 16(1): 1-9. https://doi.org/10.3760/cma.j.issn.1674-2397.2023.01.001
|
[25]
|
Li, C., Bi, H., Fu, Z., et al. (2022) Retrospective Study of the Immunogenicity and Safety of the CoronaVac SARS-CoV-2 Vaccine in People with Underlying Medical Conditions. Communications Medicine, 2, Article No. 151. https://doi.org/10.1038/s43856-022-00216-2
|
[26]
|
Harboe, Z.B., Hamm, S.R., Pérez-Alós, L., et al. (2022) Antibody Responses and Risk Factors Associated with Impaired Immunological Outcomes Following Two Doses of BNT162b2 COVID-19 Vaccination in Patients with Chronic Pulmonary Diseases. BMJ Open Respiratory Research, 9, e001268. https://doi.org/10.1136/bmjresp-2022-001268
|
[27]
|
Zhu, H.H., Sun, G.Q., Wu, J.Y., et al. (2023) Antibody Responses to an Inactivated SARS-CoV-2 Vaccine in Individuals Aged from 50 to 102 Years. Frontiers in Immunology, 14, Article 1212988. https://doi.org/10.3389/fimmu.2023.1212988
|
[28]
|
Naaber, P., Tserel, L., Kangro, K., et al. (2021) Dynamics of Antibody Response to BNT162b2 Vaccine after Six Months: A Longitudinal Prospective Study. The Lancet Regional Health—Europe, 10, Article ID: 100208. https://doi.org/10.1016/j.lanepe.2021.100208
|
[29]
|
Chaiwong, W., Takheaw, N., Laopajon, W., et al. (2022) Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study. Vaccines, 10, Article 2176. https://doi.org/10.3390/vaccines10122176
|
[30]
|
Mallah, N., Pardo-Seco, J., López-Pérez, L.R., et al. (2022) Effectiveness of COVID-19 Vaccine Booster in the General Population and in Subjects with Comorbidities. A Population-Based Study in Spain. Environmental Research, 215, Article ID: 114252. https://doi.org/10.1016/j.envres.2022.114252
|
[31]
|
Kwok, W.C., Leung, S.H.I., Tam, T.C.C., et al. (2023) Efficacy of MRNA and Inactivated Whole Virus Vaccines against COVID-19 in Patients with Chronic Respiratory Diseases. International Journal of Chronic Obstructive Pulmonary Disease, 18, 47-56. https://doi.org/10.2147/COPD.S394101
|
[32]
|
Fekete, M., Horvath, A., Santa, B., et al. (2023) COVID-19 Vaccination Coverage in Patients with Chronic Obstructive Pulmonary Disease—A Cross-Sectional Study in Hungary. Vaccine, 41, 193-200. https://doi.org/10.1016/j.vaccine.2022.11.020
|
[33]
|
Durdevic, M., Arora, A., Durdevic, D., et al. (2021) Acute Copd Exacerbation after the Second Dose of Covid-19 Vaccine. Chest, 160, A1760. https://doi.org/10.1016/j.chest.2021.07.1603
|
[34]
|
Mumm, T. and Elbashir, M. (2021) A Copd Exacerbation That Occurred after the MRNA Covid-19 Vaccine. Chest, 160, A1764. https://doi.org/10.1016/j.chest.2021.07.1607
|
[35]
|
Qin, S.X., Cheng, F.W.T., Kwok, W.C., et al. (2024) Effectiveness and Respiratory Adverse Events Following Inactivated and MRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study. Drug Safety, 47, 135-146. https://doi.org/10.1007/s40264-023-01364-7
|
[36]
|
Davis, H.E., McCorkell, L., Vogel, J.M., et al. (2023) Long COVID: Major Findings, Mechanisms and Recommendations. Nature Reviews Microbiology, 21, 133-146. https://doi.org/10.1038/s41579-022-00846-2
|
[37]
|
Pérez-González, A., Araújo-Ameijeiras, A., Fernández-Villar, A., et al. (2022) Long COVID in Hospitalized and Non-Hospitalized Patients in a Large Cohort in Northwest Spain, a Prospective Cohort Study. Scientific Reports, 12, Article No. 3369. https://doi.org/10.1038/s41598-022-18023-z
|
[38]
|
Ceban, F., Kulzhabayeva, D., Rodrigues, N.B., et al. (2023) COVID-19 Vaccination for the Prevention and Treatment of Long COVID: A Systematic Review and Meta-Analysis. Brain, Behavior, and Immunity, 111, 211-229.
|
[39]
|
Watanabe, A., Iwagami, M., Yasuhara, J., et al. (2023) Protective Effect of COVID-19 Vaccination against Long COVID Syndrome: A Systematic Review and Meta-Analysis. Vaccine, 41, 1783-1790. https://doi.org/10.1016/j.vaccine.2023.02.008
|
[40]
|
严祖喜, 杜小勇, 富冯峰, 等. 联合疫苗接种对慢性阻塞性肺疾病急性发作的影响[J]. 中国基层医药, 2018, 25(16): 2133-2135. https://doi.org/10.3760/cma.j.issn.1008-6706.2018.16.025
|
[41]
|
Ofori-Anyinam, O., Leroux-Roels, G., Drame, M., et al. (2017) Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Co-Administered with a 23-Valent Pneumococcal Polysaccharide Vaccine versus Separate Administration, in Adults ≥ 50 Years of Age: Results from a Phase III, Randomized, Non-Inferiority Trial. Vaccine, 35, 6321-6328. https://doi.org/10.1016/j.vaccine.2017.09.012
|
[42]
|
Nakashima, K., Aoshima, M., Ohfuji, S., et al. (2018) Immunogenicity of Simultaneous versus Sequential Administration of a 23-Valent Pneumococcal Polysaccharide Vaccine and a Quadrivalent Influenza Vaccine in Older Individuals: A Randomized, Open-Label, Non-Inferiority Trial. Human Vaccines & Immunotherapeutics, 14, 1923-1930. https://doi.org/10.1080/21645515.2018.1455476
|
[43]
|
朱中奎, 卢希, 唐万琴, 等. 四价流感病毒裂解疫苗和23价肺炎球菌多糖疫苗在≥60岁老年人中同时接种的安全性评价[J]. 中华预防医学杂志, 2023, 57(9): 1412-1417. https://doi.org/10.3760/cma.j.cn112150-20230417-00295
|
[44]
|
Lazarus, R., Baos, S., Cappel-Porter, H., et al. (2021) Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 Or BNT162b2) with Seasonal Influenza Vaccines in Adults in the UK (ComFluCOV): A Multicentre, Randomised, Controlled, Phase 4 Trial. The Lancet, 398, 2277-2287. https://doi.org/10.1016/S0140-6736(21)02329-1
|
[45]
|
Wang, S.Y., Duan, X.Q., Chen, B., et al. (2022) Immunogenicity and Safety of A SARS-CoV-2 Inactivated Vaccine (CoronaVac) Co-Administered with an Inactivated Quadrivalent Influenza Vaccine: A Randomized, Open-Label, Controlled Study in Healthy Adults Aged 18 to 59 Years in China. Vaccine, 40, 5356-5365. https://doi.org/10.1016/j.vaccine.2022.07.021
|
[46]
|
Chen, H., Huang, Z., Chang, S., et al. (2022) Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered with Quadrivalent Split-Virion Inactivated Influenza Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine in China: A Multicentre, Non-Inferiority, Open-Label, Randomised, Controlled, Phase 4 Trial. Vaccine, 40, 5322-5332. https://doi.org/10.1016/j.vaccine.2022.07.033
|
[47]
|
Jiang, B., Huang, Q., Jia, M., et al. (2022) Association between Influenza Vaccination and SARS-CoV-2 Infection and Its Outcomes: Systematic Review and Meta-Analysis. nese Medical Journal, 135, 2282-2293. https://doi.org/10.1097/CM9.0000000000002427
|
[48]
|
Lewnard, JA., Bruxvoort, KJ., Fischer, H., et al. (2021) Prevention of Coronavirus Disease 2019 among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions between Streptococcus Pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract. The Journal of Infectious Diseases, 225, 1710-1720. https://doi.org/10.1093/infdis/jiab128
|
[49]
|
中华预防医学会, 中华预防医学会疫苗与免疫分会. 中国百日咳行动计划专家共识[J]. 中华流行病学杂志, 2021, 42(6): 955-965. https://doi.org/10.3760/cma.j.cn112338-20210308-00186
|
[50]
|
Global Initiative for Chronic Obstructive Lung Disease (2023) Global Strategy for the Prevention,Diagnosis and Management of COPD: 2023 REPORT. https://goldcopd.org/2023-gold-report-2/
|
[51]
|
Muñoz-Quiles, C., López-Lacort, M. and Díez-Domingo, J. (2018) Risk and Impact of Herpes Zoster among COPD Patients: A Population-Based Study, 2009-2014. BMC Infectious Diseases, 18, Article No. 203. https://doi.org/10.1186/s12879-018-3121-x
|
[52]
|
中国医疗保健国际交流促进会皮肤科分会, 中华医学会皮肤性病学分会老年性皮肤病研究中心. 带状疱疹疫苗预防接种专家共识[J]. 中华医学杂志, 2022, 102(8): 538-543. https://doi.org/10.3760/cma.j.cn112137-20210828-01958
|
[53]
|
胡海峰, 詹家燚, 杜虹, 等. 肾综合征出血热患者2 245例的临床流行病学特征及预后危险因素分析[J]. 中华传染病杂志, 2023, 41(1): 70-76. https://doi.org/10.3760/cma.j.cn311365-20220422-00141
|